When lipids, cholesterol, and other substances in the blood increase and get attached to the erythrocyte surface, it leads to erythrocyte aggregation, accelerated sedimentation, and high blood viscosity. Due to the high blood viscosity, there is an accumulation of a large number of erythrocytes, oxygen reduction, decrease in blood flow velocity, resulting in certain parts of the body having an ischemic and anoxic state. Hyperviscosity is the direct cause of atherosclerosis; it also can lead to cerebral infarction, myocardial obstruction, diabetes, and aseries of serious diseases.
The blood contains a variety of fats (lipids), such as cholesterol and triglycerides. When the content of one or more lipids is too high, it is called Hyperlipidaemia, which will increase blood viscosity, causing thrombosis and blood vessel blockage. This leads to ischemia, hypoxia, and necrosis of the heart, brain, lungs, and other parts of the lower extremities.
Through LLLT, the optical energy gets converted into biological internal energy that regulates the environment of the body, reducing blood viscosity, enhancing microcirculation. This activates various enzymes, and stimulates the adrenal cortex function. There will be an increase in the glucocorticoid and decrease in the synthesis of cholesterol lipoprotein in the liver. This will also accelerate the dissolution of triglyceride and decomposition of lipoproteins. This is the process behind the reduction of blood-fat coronary heart disease, cerebral infarction, and other diseases by Curelaze.
Innovating medical technology for better healthcare. Committed to quality, safety, and clinical excellence.
© 2026 Sascan Meditech Pvt. Ltd. All rights reserved.
